TipRanks
Go Ultimate55% OFF

Evgen Pharma (TCF) Income Statement

Evgen Pharma Income Statement

Last quarter (Q4 2025), Evgen Pharma's total revenue was $0.00. In Q4, Evgen Pharma's net income was $-2.22M. See Evgen Pharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementMar 25Mar 24Mar 23Mar 22Mar 21
$ 0.00$ 0.00$ 396.00K$ 442.00K$ 0.00
$ -16.00K$ -2.11M$ 385.00K$ 429.00K$ -16.00K
$ 3.67M$ 12.00K$ 3.94M$ 5.50M$ 3.17M
Depreciation and Amortization$ 16.00K$ 69.00K$ 11.00K$ 13.00K$ 16.00K
$ -3.67M$ -2.06M$ -3.55M$ -4.99M$ -3.15M
$ -3.69M$ -2.12M$ -3.56M$ -5.07M$ -3.19M
$ 117.00K$ 39.00K$ -6.00K$ 98.00K$ 22.00K
$ -3.57M$ -2.08M$ -3.57M$ -5.01M$ -3.17M
$ -3.53M$ -1.94M$ -3.14M$ -4.04M$ -2.73M
Per Share Metrics
Basic EPS$ -0.00$ -0.00$ -0.01$ -0.01$ -0.01
Diluted EPS$ -0.00$ -0.00$ -0.01$ -0.01$ -0.01
Weighted Average Shares Outstanding2.15B538.31M274.89M274.89M274.89M
Weighted Average Shares Outstanding (Diluted)2.15B538.31M274.89M274.89M274.89M

Currency in GBP

Evgen Pharma Earnings and Revenue History

-5M-2.5M02.5M-1500 %-1250 %-1000 %-750 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin